Sponsored content

Christian Meyer and Gisela Grabow of Maiwald consider proposals under the European Commission’s Action Plan for Intellectual Property that aim to simplify extended protection for medicinal products through a unitary supplementary protection certificate

Ranjan Narula and Shipra Alisha Philip of RNA, Technology and IP Attorneys explore the factors driving rapid growth in India's medical tourism industry as fraudulent healthcare providers attempt to cash in

Min Son of Hanol IP & Law examines a new consent agreement system and international trademark partial replacement provisions under South Korea’s revised Trademark Act, and explores the concept of ‘identical trademarks’

In the first of two interviews with key figures at IPHatch competition winners, Managing IP hears how intellectual property has played an integral role in an algorithmic trading company’s growth

Katharina Pehle of Bird & Bird considers the legislative progress and potential impact of a regulation on standard-essential patents as the proposal continues to draw criticism, despite approval by the European Parliament

Fiona Yin of Saint Island International Patent & Law Offices says patent applicants should consider the Accelerated Examination Procedure for Re-examination as it offers an easier application process and quicker patent protection, with no official fee

Lawyers from Ropes & Gray joined Managing IP to discuss licensing negotiation groups

Steven Pepe of Ropes & Gray explains to Managing IP that while standard-essential patents pose several challenges for start-ups in emerging markets, they also present rich opportunities if the right strategies are adopted

Matthew Costard of Spoor & Fisher Jersey considers application of the Madrid Protocol across Africa as Ethiopia’s intellectual property practice looks set to move closer to global standards

An EPO board of appeal decision has challenged the office’s standing in requiring applicants to adapt the description text of patent applications to be in accordance with amended claims, says Edward Farrington of Inspicos

A new survey by Arnold & Porter reveals that AI adoption in life sciences is accelerating, driving innovation in drug discovery, manufacturing, and sales. The report highlights the evolution in the adoption of the technology that needs to be accompanied by good risk assessment and compliance practices

Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical patent litigation cases is set to be used in re-examination and invalidation proceedings after the CNIPA makes an invalidation decision a quasi-precedent